Cookies remember you so we can ensure to give you the best experience possible. By using this website or closing this message, you are agreeing to our cookies and policies

Do not show this message again
UK Insights

Global vaccination crisis?

Markus Kuehl

Consultant

Health 19.05.2015 / 17:30

Global Donor Vaccine Program Crisis NEW

Kantar Health looks at the challenges facing the vaccines market

The field of vaccines and immunization has been transformed globally over the last 40 years; however, the system is now in crisis, with vaccine shortages and R&D efforts considered costly and lengthy.

GAVI, the Global Vaccine Alliance, has proven to be a strong catalyst for vaccination in developing countries and continues to make an extremely important contribution to preventative medicine, and to social and economic development. But, overall, vaccination coverage levels remain stagnant and 20% of the worldwide birth cohort does not receive a single vaccine, despite some of the vaccines costing only a few cents per dose.

The Ebola epidemic and the lack of new antibiotics, highlight the problem as R&D manufacturers invest in treatments for more lucrative diseases, rather than develop vaccines to address emerging or neglected diseases.

In order to remain healthy, the vaccination ecosystem needs to provide returns on investment for donors (such as: Bill & Melinda Gates Foundation, USAID, NORAD and others) but also manufacturers:

  • Multiple suppliers are needed to avoid sole supplier situations and to help secure supply.
  • The development of vaccines for diseases that predominantly or exclusively burden poorer countries and funding for R&D activities must be secured.
  • The support of existing vaccination programs also needs to remain in focus. Supply shortages have been identified by SAGE (Strategic Advisory Group of Experts on Immunization) as a key hurdle in achieving vaccination goals. The current vaccine market appears to be not attractive enough for new market entrants to fill this gap.
  • Ongoing support is needed to sustain the vaccination policy efforts when a country no longer qualifies for GAVI funding - countries with a gross national income per capita above the eligibility threshold are no longer be available for funding.

In a world in which thousands of children continue to die from preventable infectious diseases every year, failure is not an option.

Click on the slide on the right hand side to expand it, or download the white paper below.

Source : Kantar Health


Editor's Notes

Journalists, to interview Markus Kuehl or for more information please contact us.

Latest Stories

Kantar Worldpanel confirms that women are following the catwalk and growing their hair… and shampoo sales are dropping as a result.

Supermarket sales have increased in value by 3.1% compared with last year according to the latest grocery market share figures from Kantar Worldpanel.

The latest OS data from Kantar Worldpanel ComTech puts Samsung’s overall share at a three-year high of 38.4%

With the Kantar Pulse, you can see which politicians are being talked about most on Twitter, in real time

A new report from Kantar shows that financial services organisations could be missing a £130bn opportunity – by not winning over women

Related Content